Insurance Sector: IRDAI and LIC Reforms
India's insurance sector (life and non-life) has seen major reforms: IRDAI (1999, statutory 2000) as regulator, LIC IPO (2022, Rs 21,000 cr), FDI limit raised to 74% (2021), and the shift to risk-based supervision. Life insurance penetration ~3.2%, non-life ~1%. Key products: term, ULIP, annuity, health, motor. Challenges: low penetration, misselling, claim settlement, rural reach.[TOPIC CLASSIFICATION]
- Topic type: Economy - Insurance and Financial Sector
- PYQ frequency: Medium
- Exam stage: Prelims + Mains
- Primary GS paper: GS 3
[EXAMINER REASONING]
- Trap: Confusing IRDAI (regulator) with LIC (insurer). IRDAI regulates; LIC is the largest life insurer. Many aspirants attribute LIC's decisions to IRDAI.
- Most confused: The FDI limit evolution: 26% (2000) -> 49% (2015) -> 74% (2021). Many aspirants quote the old 26% or 49% limits. Also, the difference between life (3.2% penetration) and non-life (1%) insurance penetration.
- Key anchor: IRDAI Act 1999 (statutory 2000): regulator for life, non-life, reinsurance. LIC IPO (May 2022, Rs 21,000 cr, 3.5% stake). FDI 74% (2021). Risk-based supervision (RBS) replacing rule-based. Health insurance: standardization, portability, OPD.
- Current affairs hook: LIC IPO (May 2022, Rs 21,000 cr, largest ever). FDI 74% (2021). IRDAI RBS framework (2023). Bima Sugam (digital platform). Surety bonds for infra. Climate risk disclosure. Composite license (life+non-life) discussion.
- Mains hinge: Evaluate: Has insurance liberalization improved penetration or increased misselling? The LIC IPO vs sovereign guarantee, the 74% FDI vs domestic control, and the risk-based supervision vs consumer protection are the Mains tensions.
Core Concept
Insurance sector evolution: Pre-2000 (nationalized: LIC 1956, GIC 1972) -> IRDAI 1999 (statutory 2000) -> private entry (2000) -> FDI 26% (2000) -> 49% (2015) -> 74% (2021). LIC IPO (May 2022, Rs 21,000 cr, 3.5% stake). IRDAI: regulates life, non-life, reinsurance, brokers.
Penetration (FY23): Life 3.2%, Non-life 1%, Total 4.2% (global avg ~7%). Density: Life $59, Non-life $19. LIC market share: Life ~66%, Non-life ~4% (via subsidiaries).
Products: Life (term, endowment, ULIP, annuity, pension), Non-life (motor, health, fire, marine, engineering, crop). Health: standardization (IRDAI 2020), portability, OPD cover, wellness.
Reforms: Risk-based supervision (RBS, 2023), Bima Sugam (digital marketplace), Surety bonds (infra), Climate risk (TCFD), Composite license (life+non-life). Claim settlement: IRDAI mandates 30 days. Ombudsman for grievances.
Challenges: Low penetration (rural, low income), misselling (ULIPs), claim delays, distribution (agents vs digital), climate risk (crop, property).